Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12588776 | 0.71 | ALDH1A1 (0.37) | MEN1ALDH1A1KMT2A | |
| SCHEMBL17023235 | 0.67 | MEN1 (0.31) | MEN1ALDH1A1KMT2A | |
| SCHEMBL22696784 | 0.67 | — | — | |
| Butanedione SCHEMBL5077409 | 0.63 | TSHR (0.44) | — | |
| SCHEMBL13696907 | 0.61 | HTT (0.37) | MEN1ALDH1A1KMT2A | |
| SCHEMBL6793523 | 0.61 | ALDH1A1 (0.33) | MEN1ALDH1A1KMT2A | |
| SCHEMBL15592911 | 0.60 | MEN1 (0.36) | MEN1ALDH1A1KMT2A | |
| SCHEMBL15592919 | 0.60 | MEN1 (0.36) | MEN1ALDH1A1KMT2A | |
| SCHEMBL289021 | 0.59 | — | — | |
| SCHEMBL12220362 | 0.59 | SMN1; SMN2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8354498-B2 | CD4 mimic peptides and their uses | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2013-01-15 | — | — | US | disclosed |
| EP-2035453-B1 | CD4 MIMIC PEPTIDES AND THEIR USES | COMMISSARIAT ENERGIE ATOMIQUE (FR) | 2010-09-29 | — | — | EP | disclosed |
| US-20090285798-A1 | CD4 MIMIC PEPTIDES AND THEIR USES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2009-11-19 | — | — | US | disclosed |
| EP-2035453-A2 | CD4 MIMIC PEPTIDES AND THEIR USES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008010088-A2 | CD4 MIMIC PEPTIDES AND THEIR USES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2008-01-24 | — | — | WO | disclosed |
| WO-2007144685-A1 | CD4 MIMIC PEPTIDES AND THEIR USES | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 2007-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090285798-A1 | CD4 MIMIC PEPTIDES AND THEIR USES | CD4, HGFAC, GZMB | MEN1 4438/4885ALDH1A1 4838/4885KMT2A 2095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.